• Suraksha Diagnostic intimated a board meeting on 21 May 2026 to approve audited financial results for Q4 and FY ended 31 March 2026.
• The board will consider recommending a dividend for FY26, subject to their approval during the meeting.
• The trading window closure, effective from 01 April 2026, will reopen 48 hours after the financial results declaration.